5 Einträge gefunden

1. Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.

   1. Kröger, Nicolaus-Martin
   2. Badbaran, Anita
   3. Zabelina, Tatiana
   4. Ayuketang, Francis Ayuk
   5. Wolschke, Christine
   6. Alchalby, Haefaa
   7. Klyuchnikov, Evgeny

   2013 - Forschungsinformationssystem des UKE
2. Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding study.

   1. Wolschke, Christine
   2. Stübig, Thomas
   3. Hegenbart, Ute
   4. Schönland, Stefan
   5. Heinzelmann, Marion
   6. Hildebrandt, York
   7. Ayuketang Ayuk, Francis

   2013 - Forschungsinformationssystem des UKE
3. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

   1. Lioznov, Michael
   2. El-Cheikh, J
   3. Hoffmann, Friedericke
   4. Hildebrandt, York
   5. Ayuketang Ayuk, Francis
   6. Wolschke, Christine
   7. Atanackovic, Djordje

   2009 - Forschungsinformationssystem des UKE
4. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.

   1. Atanackovic, Djordje
   2. Cao, Yanran
   3. Luetkens, Tim
   4. Panse, Jens
   5. Faltz, Christiane
   6. Arfsten, Julia
   7. Bartels, Katrin

   2008 - Forschungsinformationssystem des UKE - frei zugänglich
5. Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.

   1. Atanackovic, Djordje
   2. Arfsten, Julia
   3. Cao, Yanran
   4. Gnjatic, Sacha
   5. Schnieders, Frank
   6. Bartels, Katrin
   7. Schilling, Georgia

   2007 - Forschungsinformationssystem des UKE